NSE filing, NSE: KARURVYSYA. Summary written from the filing by ALFA Finder's alert engine.
Karur Vysya Bank Ltd: key numbers
- Share price
- ₹350.20
- Market cap
- ₹33,854 Cr
- Revenue (annual)
- ₹11,074 Cr
- Net profit (annual)
- ₹2,510 Cr
- P/E (TTM)
- 11.4×Sector 19.7×
- Promoter holding
- 1.95%-0.12% QoQ
- FII holding
- 18.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Karur Vysya Bank Ltd
All →Karur Vysya Bank Capacity Expansion
Karur Vysya Bank will inaugurate eight new branches on October 30, 2026, across several states. No financial amount is disclosed, so the filing reports branch expansion only.
- new branches
- 8.0 branches
Karur Vysya Bank Promoter Buying (Off-Market)
Karur Vysya Bank promoters executed an inter-se transfer of 3,00,000 shares within the promoter group on 23 October 2026. Net promoter group holding is unchanged, and no consideration was disclosed.
- Promoter stake change
- +0.02%
Karur Vysya Bank Promoter Selling: ₹0.93 Cr
Promoter A J Suriyanarayana sold 25,000 Karur Vysya Bank shares on the market on 19 October 2026. The trade was valued at Rs.0.93 Crore.
- Value
- ₹0.93 Cr
Karur Vysya Bank Promoter Selling: ₹0.23 Cr
Promoters and promoter group members of Karur Vysya Bank sold a total of 6,000 equity shares through open market transactions.
- Value
- ₹0.23 Cr
Karur Vysya Bank Promoter Selling: ₹0.07 Cr
Promoter and Promoter Group members sold 2,000 equity shares of Karur Vysya Bank Ltd in the open market.
- Value
- ₹0.07 Cr
Karur Vysya Bank Management Change
Karur Vysya Bank announced the completion of tenure for COO Shri Chandrasekaran M S, with Shri Ramshankar R taking charge as the new COO effective 16th October.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.